Detalles de la búsqueda
1.
Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale.
Eur J Cancer Care (Engl)
; 30(1): e13334, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33015898
2.
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.
Br J Cancer
; 120(1): 57-62, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30377342
3.
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population.
Oncologist
; 24(11): e1165-e1171, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30996007
4.
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Oncologist
; 24(3): 385-393, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606884
5.
Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review.
Future Oncol
; 15(9): 989-994, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30681378
6.
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Lancet Oncol
; 19(4): 521-536, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29545095
7.
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol
; 19(6): 799-811, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753703
8.
Challenges in ALK inhibition of ALK-positive non-small-cell lung cancer: from ALK positivity detection to treatment strategies after relapse.
Future Oncol
; 14(22): 2303-2317, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30088419
9.
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Br J Cancer
; 115(7): 789-96, 2016 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27599039
10.
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.
Lancet
; 384(9944): 665-73, 2014 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24933332
11.
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
Lancet Oncol
; 13(3): 247-55, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22341744
12.
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature.
Immunotherapy
; 14(4): 175-181, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34873918
13.
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Br J Cancer
; 115(9): e16, 2016 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27727233
14.
Anti PD-L1 antibody: is there a histologic-oriented efficacy? Focus on atezolizumab in squamous cell non-small cell lung cancer.
Front Biosci (Schol Ed)
; 13(2): 190-201, 2021 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879471
15.
Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma.
Cancers (Basel)
; 13(5)2021 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33800236
16.
Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study.
Clin Lung Cancer
; 22(4): 361-370.e3, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32732073
17.
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
Eur J Cancer
; 148: 190-201, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744715
18.
What are the options for non-small-cell lung cancer patients post second-line therapy?
Future Oncol
; 11(17): 2379-82, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26270000
19.
Disseminated intravascular coagulation in advanced lung adenocarcinoma during first-line pembrolizumab.
Immunotherapy
; 12(9): 629-633, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32418466
20.
Aplastic anemia in a patient with advanced lung adenocarcinoma during first line osimertinib: A case report and literature review.
Lung Cancer
; 142: 120-122, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32145595